The final, formatted version of the article will be published soon. ABSTRACT Background: Cisplatin (DDP) is the first-in-class drug for advanced and non-targetable non-small-cell lung cancer (NSCLC).
Sepsis is a systemic inflammatory response syndrome triggered by infection that frequently involves multiple organs, ultimately leading to multiple organ failure. Among affected organs, the lungs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback